Phytosphingosine Salicyloyl + Pramoxine Hydrochloride

20 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

500.0%

Death Rate

Active Ingredients

Phytosphingosine SalicyloylPramoxine Hydrochloride

Administration Routes

TopicalOphthalmic

Species Affected

Dog 16

Human 3

Cat 1

Most Affected Breeds

Unknown 3

Retriever - Golden 3

Retriever - Labrador 2

Dachshund (unspecified) 1

Maltese 1

Spaniel - Cocker American 1

Domestic Shorthair 1

Shepherd Dog - German 1

Brittany 1

Dog (unknown) 1

Most Reported Reactions

Pruritus 4

Erythema (for urticaria see Immune SOC) 3

Glaucoma 3

Hives (see also 'Skin') 2

Application site erythema 2

Application site pruritus 2

Lack of efficacy - NOS 2

Urticaria 2

Accidental exposure 1

Red eye 1

Eye irritation 1

Application site reddening 1

Outcome Breakdown

Recovered/Normal

9 (45.0%)

Ongoing

6 (30.0%)

Outcome Unknown

4 (20.0%)

Euthanized

1 (5.0%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.